HERD IMMUNITY THRESHOLD HARDER—Vaccine herd immunity is becoming harder. The formula is (1-(1/R0)) depends on virus contagiousness, which #B117 variant is 40-80% higher & will be dominant soon. So instead of 70% immune, we will now need 80-85%.🧵#COVID19 washingtonpost.com/health/covid-m…
2) “If a more transmissible strain becomes dominant, “that level of coverage needed for herd immunity would become higher, in the 80 to 85 percent range,” Jay Butler, deputy director for infectious diseases at CDC.”
3) Also hurting this target number is that the new South Africa 🇿🇦 #B1351 mutated variant (and likely the Brazil #P1 variant too because it shares the troublesome E484K mutation) is significantly dropping the protection offered by prior infection or from vaccines (many studies).
4) That’s why experts say “The latest bulletins about variants and the Novavax results in South Africa “really does make the prospect of herd immunity, at least before next winter, much less likely,” said Christopher Murray, director of the University of Washington’s @IHME_UW.
5) All three of the most-scrutinized “variants of concern” have arrived in the US. As of midday Saturday there were more than 430 reported cases involving 🇬🇧 variant #b117, and one case, in Minnesota of 🇧🇷 variant #P1 plus 🇿🇦 #B1351 found in SC and Maryland.
6) vaccines appear to work well against #B117 variant. But J&J vaccine did not appear to prevent disease quite as well in 🇿🇦 & LATAM — where problematic variants are spreading. And Novavax data showed a dramatic drop in effectiveness against the B.1.351 variant circulating in 🇿🇦.
7) “So far there is limited evidence of changes in disease severity from these variants. The exception is the variant spreading in the United Kingdom, which may be roughly 30 percent more lethal”
I reviewed the data. It’s concerning. See discussion 🧵 on the 10 studies ⬇️
8) worrisome was the recent data that found blood from 48% of people previously recovered from #COVID19 in the 1st 2020 wave in South Africa did not recognize the new #B1351 variant — “complete immune escape”. 90% had lower neutralization.
9) this is why South Africa’s CDC @nicd_sa put out this stunning statement last week on the “reinfection” potential of the new #B1351 variant. Because of the 48% of recovered #COVID19 patients with “complete immune escape”
10) here is now the math of #B117 variant would compare with the old common variant... if there is just 10 cases now, there would be 2000+ by end of March—200x. But we know there are likely much more already now.
13) also the herd immunity threshold of 80-85% includes children. About ~20% of the US is under 16 years of age. (Pfizer is approved for 16+ while Moderna approved for 18+). So basically we need 100% of adults vaccinated just to achieve 80% if no kids under 16 vaccinated yet.
14) That said, pediatric trials of the vaccines are underway already. They need to do more careful dosing studies for kids because kids age 1-15 vary in size considerably. China says its pediatric trials done by March. Western vaccine trials for kids likely late spring or summer.
15) That said, herd threshold can be lower if there is some natural immunity (Hope not too much since that is the dangerous approach & imperfect), and mitigation. Mitigation lowers the effective R. Basically need 80-85% immune if we did zero mitigation anymore (normal life).
16) We are mostly holding the effective R under 2 in most places, and under 1 in some places with masks, closures, etc. but every release valve we reopen, we raise the R and raise the effective % we need vaccinated again. It’s combined gas pedal + braking system we need to use.
17) but when I see this video... it makes me think mitigation is a lot harder than we think it is. More people vaccinated sooner is what we need if lockdowns aren’t enforced enough.
BREAKING—CDC released 1st month vaccine report. Just under 13 million vaccinated over 30 days, or just ~431k per day. Relative to US pop, blacks & Latinos are underrepresented, though partly to HCW & elderly.
NOT GOOD—so it seems 🇬🇧 government researchers have discovered that the already more contagious #B117 has further acquired the other troublesome E484K mutation seen in 🇿🇦#B1351 & 🇧🇷#P1 variants—in 11 patients. E484k is blamed for partial vaccine-evasion.🧵 assets.publishing.service.gov.uk/government/upl…
2) Moreover, they believe the 11 samples of #b117 variant that acquired the new E484K acquired them independently of each other (not just one single origin). This suggests convergent evolution taking place—where it evolves to acquire E484K separately—which indicates it is key.
3) One expert thinks it’s because the E484K might enhance another mutation seen in #B117, thereby letting the virus “grip” the human ACE2 receptor (targeted entry portal into human cells) stronger in a more stable way.
CONSPIRACY RUN AMOK—A nurse who got vaccine on live TV and fainted briefly (and then went back on TV saying she’s okay) has anti-vaxxers and pandemic deniers running amok insisting she is dead. There is no end in sight to the online harassment. #COVID19 thedailybeast.com/anti-vaxxers-w…
2) Here was how all the above sorta started. Someone deceptively edited a video...
3) it started in mid Dec but it’s still going. “According to all official sources, she is alive and well and working as a nurse in Chattanooga. Last week, she was pictured on the front of local newspaper caring for a police chief who had been in hospital for nearly 100 days.”
💡EARLY CONVALESCENT PLASMA WORKS—2 large studies shows early use of high antibody concentration CP therapy prevents severe #COVID19.
📌Study 1: Trial of high titer CP vs placebo—cuts severe COVID risk by 1/2!
📌Study 2: High titer CP cuts death risk by 1/3 vs low titer CP🧵
2) Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
➡️Conclusion: Early administration of high-titer convalescent plasma against SARS-CoV-2 to mildly ill infected older adults reduced the progression of #COVID19 by 48%.
3) Among patients hospitalized with Covid who were not receiving mechanical ventilation, transfusion of plasma with higher anti–#SARSCoV2 IgG antibody levels was associated with a lower risk of death than transfusion of plasma with lower antibody levels. nejm.org/doi/full/10.10…